Chemical activators of family with sequence similarity 217, member B can influence this protein's activity through various signaling pathways that converge on its phosphorylation state. Forskolin acts directly on adenylate cyclase to raise cyclic AMP levels, which in turn activate protein kinase A (PKA). PKA is then capable of phosphorylating family with sequence similarity 217, member B, potentially altering its activity. Similarly, IBMX prevents the degradation of cAMP and cyclic GMP (cGMP), leading to their accumulation and a heightened activation of PKA or protein kinase G (PKG), which can also target and modify the activity of family with sequence similarity 217, member B. Epinephrine and PGE2 function through their respective receptors to activate adenylate cyclase, thus enhancing cAMP production and PKA activation, which again creates the conditions for the phosphorylation of family with sequence similarity 217, member B.
Additionally, certain signaling molecules work through calcium-dependent mechanisms to activate family with sequence similarity 217, member B. Angiotensin II and bradykinin both initiate signaling cascades via G-protein-coupled receptors (GPCRs) that lead to the activation of phospholipase C and the subsequent release of intracellular calcium. This increase in calcium can activate calcium/calmodulin-dependent protein kinases (CaMKs), which are then capable of phosphorylating family with sequence similarity 217, member B. Histamine, through its action on H1 receptors, can similarly raise intracellular calcium levels and activate CaMKs. Nicotine, glutamate, and ATP, by stimulating their respective receptors, can also increase intracellular calcium, which then activates CaMKs that phosphorylate family with sequence similarity 217, member B. Acetylcholine engages muscarinic receptors to activate a GPCR-mediated pathway involving phospholipase C, leading to increased calcium and the activation of CaMKs. Lastly, anandamide, by interacting with cannabinoid receptors, can elevate cAMP levels, thereby activating PKA, which can then phosphorylate family with sequence similarity 217, member B. Each of these chemicals, through their unique pathways, can converge on the common endpoint of activating family with sequence similarity 217, member B by promoting its phosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX acts as a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. Elevated levels of these cyclic nucleotides can enhance the activation of PKA or PKG, respectively, which can then phosphorylate and activate family with sequence similarity 217, member B. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors which in turn can activate adenylate cyclase, leading to increased cAMP levels and subsequent activation of PKA. PKA then has the potential to phosphorylate and thus activate family with sequence similarity 217, member B. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G-protein-coupled receptors (GPCRs), which can activate adenylate cyclase, enhance cAMP production, and activate PKA. Activated PKA is capable of phosphorylating and activating family with sequence similarity 217, member B. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II engages with GPCRs, particularly the AT1 receptor, which can lead to the activation of phospholipase C and release of intracellular calcium. The increase in calcium can activate calcium/calmodulin-dependent protein kinases (CaMK), which may phosphorylate and activate family with sequence similarity 217, member B. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to its GPCRs, such as the H1 receptor, which activates phospholipase C, IP3, and intracellular calcium release. The calcium signal can activate CaMKs, potentially leading to the phosphorylation and activation of family with sequence similarity 217, member B. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin, through its B2 receptor, can activate phospholipase C and increase intracellular calcium, which activates CaMKs. CaMKs have the potential to phosphorylate and activate family with sequence similarity 217, member B. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate activates its receptors which can result in calcium influx through NMDA receptors or voltage-gated calcium channels. This calcium influx can activate CaMKs, which can phosphorylate and activate family with sequence similarity 217, member B. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
ATP can bind to purinergic receptors, such as P2X receptors that are ligand-gated ion channels, leading to calcium influx. The rise in intracellular calcium levels can activate CaMKs, which are known to phosphorylate and activate target proteins, including potentially family with sequence similarity 217, member B. | ||||||